Publication:

lncRNA requirements for mouse acute myeloid leukemia and normal differentiation

Loading...
Thumbnail Image

Open/View Files

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

eLife Sciences Publications, Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Delás, M. J., L. R. Sabin, E. Dolzhenko, S. R. Knott, E. Munera Maravilla, B. T. Jackson, S. A. Wild, et al. 2017. “lncRNA requirements for mouse acute myeloid leukemia and normal differentiation.” eLife 6 (1): e25607. doi:10.7554/eLife.25607. http://dx.doi.org/10.7554/eLife.25607.

Abstract

A substantial fraction of the genome is transcribed in a cell-type-specific manner, producing long non-coding RNAs (lncRNAs), rather than protein-coding transcripts. Here, we systematically characterize transcriptional dynamics during hematopoiesis and in hematological malignancies. Our analysis of annotated and de novo assembled lncRNAs showed many are regulated during differentiation and mis-regulated in disease. We assessed lncRNA function via an in vivo RNAi screen in a model of acute myeloid leukemia. This identified several lncRNAs essential for leukemia maintenance, and found that a number act by promoting leukemia stem cell signatures. Leukemia blasts show a myeloid differentiation phenotype when these lncRNAs were depleted, and our data indicates that this effect is mediated via effects on the MYC oncogene. Bone marrow reconstitutions showed that a lncRNA expressed across all progenitors was required for the myeloid lineage, whereas the other leukemia-induced lncRNAs were dispensable in the normal setting.

Description

Research Data

Keywords

lncRNA, hematopoiesis, leukemia, c-Myc, Mouse

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories